--- title: "Weekly Recap: Bayer AG Q2 sales growth and Roundup settlement opt-out cap" type: "News" locale: "en" url: "https://longbridge.com/en/news/295360880.md" description: "Bayer AG reported Q2 sales growth of 2% to €10.9B but saw core EPS drop 16.7%. The company strengthened its balance sheet with a $3B Apollo equity injection and $5B bond issuance, following a Supreme Court win that eased litigation risks. Bayer is reorganizing U.S. Roundup operations under Ruveon LLC, setting an opt-out cap for settlements, while breakup talks persist amid high debt." datetime: "2026-08-10T05:15:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295360880.md) - [en](https://longbridge.com/en/news/295360880.md) - [zh-HK](https://longbridge.com/zh-HK/news/295360880.md) generator: "portal-rs" --- # Weekly Recap: Bayer AG Q2 sales growth and Roundup settlement opt-out cap Bayer AG (XETR:BAYN) reported modest sales growth and mixed earnings, laid out 2026 targets and net-debt goals, and strengthened its balance sheet via a $3B Apollo equity injection and $5B bond issue while advancing a Roundup settlement, U.S. reorganization under Ruveon LLC and talks of a breakup. **Previous Week Recap** - **BAYN Q2 Sales Up, Core EPS Down**: Bayer (BAYN) Q2 sales €10.87–10.9B (+2% YoY); EBITDA before specials rose; core EPS down ~16.7%; H1 sales €24.3B (+3%); confirms 2026 sales €44.7–46.7B, core EPS €4.20–4.70, net debt €29–30B. 3 sources - **Bayer Roundup U.S. Settlement Framework**: Bayer AG (BAYN) set a U.S. Roundup settlement framework: needs under 650 plaintiff opt-outs to proceed; may cut up to $400M from fund if opt-outs exceed threshold; opt-out vetting included. Reuters - **Supreme Court Win Eases Risk; Apollo Investment Increases**: Bayer (BAYN) saw litigation risk ease after a Supreme Court win. Apollo invested €3B equity and Bayer issued $5B in bonds, strengthening its capital structure and balance sheet. Quartr - **U.S. Roundup Operations Reorganized Under Ruveon**: Bayer AG (BAYN) said it’s reorganizing U.S. Roundup operations under Ruveon LLC. Restructuring may include additional divestitures or spin-offs as part of broader U.S. reorganization efforts. Reuters - **Bayer Breakup Talk: Split, IPOs Possible**: Bayer AG (BAYN) breakup discussed: split into agriculture, pharma and consumer health; possible partial Monsanto IPO. High debt and cash outflows limit options; pharma must be strengthened first. Dow Jones Newswires - **Low Rhine Levels Not Disrupting Operations**: Bayer (BAYN) says low Rhine water levels have so far not disrupted operations or supply chains; company reports no current operational impact from reduced river levels. Reuters **Disclaimer** This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources. ### Related Stocks - [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md) - [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md) - [APO.US](https://longbridge.com/en/quote/APO.US.md) - [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md) - [APO-A.US](https://longbridge.com/en/quote/APO-A.US.md) - [APOS.US](https://longbridge.com/en/quote/APOS.US.md) ## Related News & Research - [Bayer says Japan approves sevabertinib for HER2-mutant NSCLC](https://longbridge.com/en/news/296745277.md) - [Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Increases By 94.9%](https://longbridge.com/en/news/296026963.md) - [Apollo, In Letter To California AG, Says It Experienced A Social Engineering Incident](https://longbridge.com/en/news/296626710.md) - [Apollo Gets Hacked: Private Equity Giant Confirms Major Data Breach](https://longbridge.com/en/news/296643394.md) - [Private equity firm Apollo confirms data breach amid hacking wave targeting financial giants](https://longbridge.com/en/news/296625510.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**